# Short Course Terlipressin for Control of Acute Variceal Bleeding

> **NCT00369694** · PHASE4 · COMPLETED · sponsor: **Aga Khan University** · enrollment: 130 (actual)

## Conditions studied

- Hemorrhage
- Esophageal Varices
- Portal Hypertension

## Interventions

- **DRUG:** Terlipressin
- **DRUG:** Terlipressin & then Dummy

## Key facts

- **NCT ID:** NCT00369694
- **Lead sponsor:** Aga Khan University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2008-07
- **Final completion:** 2008-08
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2008-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00369694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00369694, "Short Course Terlipressin for Control of Acute Variceal Bleeding". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00369694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
